Related Experiment Video
Updated: May 7, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Rho/Rho-associated kinase pathway in glaucoma (Review)
Jing Wang1, Xiaohong Liu, Yisheng Zhong
1Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai 200025, P.R. China.
Inhibiting the Rho/ROCK pathway can lower intraocular pressure by relaxing the trabecular meshwork and reduce scarring. This pathway also offers neuroprotection for the optic nerve, making it a promising target for glaucoma treatment.
Area of Science:
- Ophthalmology
- Cell Biology
- Pharmacology
Background:
- The Rho/ROCK pathway regulates cellular functions crucial for eye health, including cytoskeletal integrity and extracellular matrix synthesis.
- This pathway influences the permeability of Schlemm's canal endothelial cells and trabecular meshwork (TM) contraction.
Purpose of the Study:
- To explore the therapeutic potential of targeting the Rho/ROCK pathway for anti-glaucoma treatments.
- To evaluate the effects of Rho/ROCK inhibition on intraocular pressure (IOP), ocular blood flow, and optic nerve protection.
Main Methods:
- The study reviews the known roles of the Rho/ROCK pathway in ocular tissues and its modulation by inhibitors.
- Analysis of the pathway's impact on TM contraction, aqueous humor outflow, and fibroblast transdifferentiation.
Main Results:
- Inhibiting the Rho/ROCK pathway leads to TM relaxation, increasing outflow facility and reducing IOP.
- ROCK inhibitors demonstrate anti-scarring effects by preventing tenon fibroblast transdifferentiation into myofibroblasts.
- Rho/ROCK pathway inactivation promotes optic nerve neuroprotection, enhances ocular blood flow, and supports retinal ganglion cell (RGC) survival and axon regeneration.
Conclusions:
- The Rho/ROCK pathway is a significant target for novel anti-glaucoma therapies due to its multifaceted roles in IOP modulation, anti-scarring, and neuroprotection.
- Targeting this pathway holds promise for future human therapeutic applications in managing glaucoma.
Related Concept Videos
Glaucoma: Overview
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Cell Polarization by Rho Proteins
Angle Closure Glaucoma: Treatment

